World's Best Scientists 2026 revealed!
Hans-Henrik Parving

Hans-Henrik Parving

D-Index & Metrics

Medicine

D-Index
143
Citations
106006
World Ranking
1473
National Ranking
21

Overview

Hans-Henrik Parving is affiliated with the University of Copenhagen in Denmark. Their research primarily falls within medicine, with significant contributions to subfields including endocrinology, diabetes and metabolism, nephrology, molecular biology, surgery, and pulmonary and respiratory medicine.

Their scientific work covers key topics such as diabetes treatment and management, chronic kidney disease and diabetes, pancreatic function and diabetes, metabolism related to diabetes and cancer, ferroptosis and cancer prognosis, iron metabolism and disorders, as well as ion transport and channel regulation.

Among their recent publications are:

  • Low-dose sodium-glucose cotransporter 2 inhibitor ameliorates ischemic brain injury in mice through pericyte protection without glucose-lowering effects, 2022, Communications Biology
  • SGLT2 inhibition mitigates transition from acute kidney injury to chronic kidney disease by suppressing ferroptosis, 2024, Scientific Reports
  • Roles of Sodium-Glucose Cotransporter 2 of Mesangial Cells in Diabetic Kidney Disease, 2021, Journal of the Endocrine Society
  • The presence of sodium glucose co-transporter 2 in mesangial cells and pericytes and its roles in mesangial lesions and in capillaries under diabetic and ischemic conditions, 2022, Diabetes Research and Clinical Practice

They frequently publish in the following journals:

  • Communications Biology
  • Scientific Reports
  • Journal of the Endocrine Society
  • Diabetes Research and Clinical Practice

Hans-Henrik Parving often collaborates with a range of co-authors, including Kuniyuki Nakamura, Takanari Kitazono, Toshiaki Nakano, Masamitsu Takashima, and Takuya Kiyohara.

Best Publications

  • EFFECTS OF LOSARTAN ON RENAL AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND NEPHROPATHY

    Barry M. Brenner;Mark E. Cooper;Dick De Zeeuw;William F. Keane

  • Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes

    Peter Gæde;Pernille Vedel;Nicolai Larsen;Nicolai Larsen;Gunnar V.H. Jensen

  • Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes

    Peter Gæde;Henrik Lund-Andersen;Hans-Henrik Parving;Oluf Pedersen

  • The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.

    Hans-Henrik Parving;Hendrik Lehnert;Jens Bröchner-Mortensen;Ramon Gomis

  • Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis

    R. Clarke;R. Collins;S. Lewington;A. Donald

  • A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

    Marc A Pfeffer;Emmanuel A. Burdmann;Chao Yin Chen;Mark E. Cooper

  • Rosuvastatin and cardiovascular events in patients undergoing hemodialysis

    Bengt C. Fellström;Alan G. Jardine;Roland E. Schmieder;Hallvard Holdaas

  • Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes

    Hans-Henrik Parving;Hans-Henrik Parving;Barry M. Brenner;John J.V. McMurray;Dick de Zeeuw

  • Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy

    Hans-Henrik Parving;Frederik Persson;Julia B. Lewis;Edmund J. Lewis

  • Nephropathy in diabetes

    Mark E Molitch;Ralph A DeFronzo;Marion J Franz;William F Keane

  • Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study

    Peter Gaede;Pernille Vedel;Hans Henrik Parving;Oluf Pedersen

  • EARLY AGGRESSIVE ANTIHYPERTENSIVE TREATMENT REDUCES RATE OF DECLINE IN KIDNEY FUNCTION IN DIABETIC NEPHROPATHY

    Hans-Henrik Parving;UllaM Smidt;AllanR Andersen;PerAa Svendsen

  • Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL

    Dick De Zeeuw;Giuseppe Remuzzi;Hans Henrik Parving;William F. Keane

  • Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease

    Dick de Zeeuw;Tadao Akizawa;Paul Audhya;George L. Bakris

  • Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy

    Dick De Zeeuw;Giuseppe Remuzzi;Hans Henrik Parving;William F. Keane

  • Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: Progressive, interrelated, and independently associated with risk of death

    Coen D.A. Stehouwer;Mari-Anne Gall;Jos W.R. Twisk;Elisabeth Knudsen

  • Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts

    Brad C. Astor;Kunihiro Matsushita;Ron T. Gansevoort;Marije Van Der Velde

  • Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial

    Dick De Zeeuw;Rajiv Agarwal;Michael Amdahl;Paul Audhya

  • Prevention of diabetic renal disease with special reference to microalbuminuria

    Carl Erik Mogensen;William F. Keane;Peter H. Bennett;George Jerums

  • Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion

    H H Parving;B Oxenbøll;P A Svendsen;J S Christiansen

Frequent Co-Authors

Peter Rossing
Peter Rossing University of Copenhagen
Lise Tarnow
Lise Tarnow Steno Diabetes Center
Oluf Pedersen
Oluf Pedersen University of Copenhagen
Dick de Zeeuw
Dick de Zeeuw University of Groningen
Barry M. Brenner
Barry M. Brenner Brigham and Women's Hospital
Giuseppe Remuzzi
Giuseppe Remuzzi Mario Negri Institute for Pharmacological Research
Mark E. Cooper
Mark E. Cooper Monash University
William F. Keane
William F. Keane University of Minnesota
Coen D.A. Stehouwer
Coen D.A. Stehouwer Maastricht University
Nish Chaturvedi
Nish Chaturvedi University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in healthcare but not sure that traditional medical school is the right fit? The healthcare field offers a broad range of online degrees and specialized career pathways that are both flexible and in demand. For those who enjoy working with data and patient records, a bachelor of health information management online program can open doors to roles in managing health data and ensuring the accuracy of medical information.

If you prefer working in administrative healthcare, consider medical billing and coding online courses, which prepare you for essential roles processing medical claims and insurance forms. These skills are highly transferable and sought after by employers.

Nursing is another rewarding option. There are several affordable online fnp programs for those looking to become family nurse practitioners and advance their clinical skills. If you are looking for entry points into nursing, you might explore what is the cheapest online college for nursing? to find budget-friendly options.

Best Scientists Citing Hans-Henrik Parving

Trending Scientists

Recently Published Articles